initi coverag outperform rate target price
strateg asset cusp harvest cycl valuat hold us back initi coverag neutral rate tp
reset baselin recoveri lower estim target price
tripl quadrupl check model yep number look fine pellet premium revis estim
valuat reset more-than-compens new risk rais estim lower target price
trend mix manag drive upsid rais estim
kick potenti posit catalyst street rais estim lower target price
dig put take fulfil ship rais estim target price
sync interchang psr prelud lower estim
puls check deal rais target price
go get tough estim reduc tp reduc
dupix asthma approv posit
mcveigh weekli servic recap minut
surf hr lll ride consolid wave
 nestl unilev spark hope higher price let get carri away
lean week earn round
cleveland fed mester speak
cleveland fed mester speak
analyst disclosur credit suiss seek busi compani cover research
report result investor awar firm may conflict interest could affect
object report investor consid report singl factor make invest
seri unfortun event updat anoth blow boost
psych hospit gener outsourc outperform question week
find hot spot hous heat map
rememb rememb novemb
 mich sentiment oct cs estimate
 mich yr inflat oct cs
 mich yr inflat oct
receiv product pleas specifi credit suiss contact email call
volatil market take time heal
octob publish lean volume spike highlight invest volatil jump typic lead
averag return subsequ month believ investor opportunist extend risk chart
clearli show unusu market remain jitteri time-perhap months-follow spike
sign stress outsid stock
histor vast major bear market coincid recess contrast drawdowns-such
caus liquid event result addit monitor harbing econom weak also track area
market stress includ asset class volatil currenc commod rate sign credit disrupt
current time indic contagion market stress almost entir contain equiti bullish signal
stock
market liquid despit recent sell stock spread well-behav liquid abund
volatil across asset vix vvix volatil volatil spike similar metric remain check non-
 equiti well ficc market
currenc stress across major currenc seem quit normal except pound brexit-rel
bank cd littl system concern across financi institut appear evid save small number troubl european
report concentr bank last week focu shift tech compani week hear
amazon alphabet tech ep expect grow
 market cap report earn beat compani surpass
bottom-lin estim compar past year
expect revenu earn ep growth respect ep pace
assum typic beat rate remaind season
recent tax chang ad bottom-lin exclud reduct tax burden trend ep growth
pace vs includ
today compani repres report result includ corp
compani report friday includ
procter gambl top forecast strong organ top-lin growth pg announc billion buy-back program
honeywel despit beat result strength aerospac unit share fell tariff
expect point gradual recoveri global demand despit drop us frack
state street fell short estim lower invest servic fee flat asset custodi share declin
suntrust surpass project lower expens credit cost tax benefit net reserv releas sti share
receiv product pleas specifi credit suiss contact email call
initi coverag outperform rate target price
lead antibiot target seriou hospit infect entasi two asset acinetobact
infect zoliflodacin gonorrhea key valu driver stock
develop address difficult-to-treat acinetobact infect resist rate mortal rate
carbapenem-resist infect shown promis preclin efficaci good tissu distribut
clean safeti profil date model probabl success program howev project potenti
global peak opportun set
antibiot challeng invest creat opportun select buy investor edg
away antibacteri invest past three four year owe challeng reimburs environ
compound lacklust commerci launch recent approv agent increas pharma compani
exit space visibl low see sentiment potenti improv next year propos chang
reimburs model new incent put place multidrug-resist infect increas problem
us global extrem high cost healthcar system death annual
us among patient treat hospit gram-neg infect ettx offer differenti strategi develop
candid address critic challeng antimicrobi resist
valuation-initi coverag outperform rate tp target price base blend dcf
project risk thesi includ clinic trial failur regulatory/commerci headwind current fund
suffici critic readout
strateg asset cusp harvest cycl valuat hold us back initi coverag neutral rate tp
initi coverag neutral rate target price
invest case given surveymonkey core proposit help busi gather extern intern data make
inform strateg decis believ remain valuabl critic asset furthermor follow
invest upgrad product suit enterpris consumpt believ initi stage
harvest cycl expect extract lift annual recurr revenu result said stock
current trade within target price sidelin wait favor entri point factor
may prompt us chang invest stanc includ higher-than-anticip lift faster-than-expect
growth paid user and/or better-than-expect margin due lower custom acquisit cost surveymonkey
continu reap benefit well-known brand
valuat in-lin methodolog use valu coverag univers target price base
discount cash flow analysi assum wacc termin growth rate risk includ
loss user higher mix custom acquisit paid channel competit googl form
receiv product pleas specifi credit suiss contact email call
reset baselin recoveri lower estim target price
reset expect investor expect earn report neg impact stock set
realist achiev expect next quarter rebas estim management credibl describ
improv global market onshor us frack see continu price pressur lower util
custom suspend oper holiday earli well fit investor understand drill
servic continu well mitig impact significantli increas likelihood futur upward
earn revis primari driver stock perform onshor shallow market continu improv
oper util full year-end bia price clearli higher quarter result vs
expect somewhat mix effect guid cyclic bottom next quarter two
investor better believ improv recoveri
return management give guidanc board action concern dividend management note
strong cash flow ytd plan eurasia drill compani edc broad goal
return cash sharehold huge surpris would expect dividend boost around earn
report estim ebitda capital-expenditure current dividend
avail cash cash equival today current yield
number take ebitda move target price ebitda
estim give specif number indic ep would q/q ep move
risk thesi includ oil price nam recoveri intern price
tripl quadrupl check model yep number look fine pellet premium revis estim
continu view secular shift toward meaning higher base product us clear valid
strategi spend capit enter market potenti add anoth unit point
next year secular shift product migrat toward value-add sheet also add growth curv
premium iron unit see ebitda tailwind higher pellet premium vale set level
typic novemb see off-set higher unit cost lower price moder interseg
volum loss
pellet dynam bullish structur shift higher pellet premium bullish ebitda next sever
year project atlant basin premium near vs provid uplift
asp see neg asp impact lower price slightli higher freight lower
blast furnac demand us remain solid near-term given tariff structur howev new buildout like
drive us bof share lower time frame
inflect point model gener net debt fall
target point capit return becom potenti big catalyst stock
remain track custom interest strong rais ep higher asp view
valuat trade ev/ebitda yield view fair given cyclic concern
remain neutral valuat also cautiou medium term view said iron ore trend look better
cs commod team forecast earn bia remain upsid risk commod price
receiv product pleas specifi credit suiss contact email call
valuat reset more-than-compens new risk rais estim lower target price
caus outsiz reaction neg includ slow internat trend ex fx vs
already-tough stock backdrop stock int exposur china slow ex-fx vs
though timing/shift-rel re-accel mid-teen gm miss flat vs street van rev
deceler slightli ex-fx vs internat concern think market would
focus accel van stack van guid still conserv
fundament stori still intact step back rais revenue guid ex-sears/fx/reef van momentum
remain strong make guid look extrem conserv impli van rev vs
key reason impli gm slowdown-which see conserv last north face final
acceler tnf timberland ebit margin prior peak ep power-a big cushion
slowdown van trend
sotp attract input assum today stock move larg chang valuat outdoor cse
ebitda in-lin outdoor/brand peer work cse ebitda in-lin wd jean cse ebitda base
div yield math impli valuat activ van compress today vs
prev -mean activ valuat at/below best-in-class peer like despit higher growth
margin well today
valuat trim tp base ebitda slightli average vs
peer vs prev due less visibl internat trend risk deceler macro integr
friday citizen report ep integr cost oper ep came
ahead estimate/consensu revenu came ahead expect nii fee
incom forecast expens forecast inclus acquisition-rel expens credit cost
lower/bett well loss rate line/reserv releas unanticip benefit manag spoke pipelin strength
product line build-out asset sensit support fairli optimist forward look rais estim
incorpor upsid take guidanc specif rais estim
forecast unchang per share target price stand base case estim risk/sensit driven
level econom activ loan demand yield curv credit qualiti degre competit across
bank product market
highlight revenu growth year year thank benefit higher interest rate loan growth balanc
sheet optim loan balanc yr/yr qtr/qtr manag speak healthi commerci
lend pipelin healthi capit market pipelin well averag deposit increas qtr/qtr non-interest bear
npa declin nco tick anticip
lowlight interest-bear deposit cost rose surpris given increasingli visibl competit
deposit expect trend continu launch citizen access lend support deposit growth albeit
competit price offer
trend mix manag drive upsid rais estim
suntrust report earn per oper ep ex tax benefit either way ahead
estim consensu earn upsid driven lower forecast credit costs/reserv releas lower
forecast expens revenu came bit weaker note strength lend invest bank pipelin
determin activ manag expens acceler share repurchas forward look appear much intact
forward look factor upsid benefit acceler share repurchas rais estim
old estim unchang target price unchang base case estim
risk/sensit driven first foremost level econom activ turn drive level shape
yield curv credit qualiti trend capit market condit
fundament snapshot net interest revenu came estim loan qtr/qtr averag deposit
balanc flattish nim compress qtr/qtr line recent manag commentari
forecast flat ii non-interest incom also estim without credit card reward charg
may prove time simpli current oper environ iii lower forecast
expens off-set revenu shortfal drive effici iv credit cost well
forecast loss rate modestli higher benefit net reserv releas latter unanticip
acceler capit return manag intend acceler share buyback floor
ccar author share buyback adjust forecast accordingli
receiv product pleas specifi credit suiss contact email call
kick potenti posit catalyst street rais estim lower target price
event decreas daili activ user dau expect work assumpt snap
revamp android app releas switch maintain outperform rate lower price target vs
prior roll valuat paramet decreas long-term free cash flow estim
ep vs prior
invest case prior model contempl releas updat android app
seem tbd elect project on-going dau attrit increas overal risk
estim would rather see snap ship fully-vet product dislik use ev/us form user-
base valuat point snap share current per dau vs fb share
bottom respect android app releas still front us maintain
outperform rate follow updat invest thesi point potenti user growth recoveri android app
releas advertis revenu growth acceler earlier snap lap balanc
reserved/programmat transit headwind snap scarc asset offer advertis access covet younger
valuat base target price dcf vs prior increas weight
averag cost capit vs prior view greater level uncertainti estim maintain
termin growth rate competit long list well-heel competitor risk target estim
dig put take fulfil ship rais estim target price
event given proxim end-of-year roll forward valuat paramet rais price target
vs prior made extens chang model recalibr growth driver well
model increment ship fulfil expens ep estim vs prior
invest case note believ amazon set continu reap fulfil ship cost
benefit current harvest cycl given greater fc throughput robot better unit econom flex
deliveri network rise order densiti said offset recent announc
minimum wage increas propos usp fee increas believ former result increment
increas respect latter anoth
conserv elect layer maximum cost impact two factor estim otherwis
invest thesi share remain unchang maintain outperform rate base follow
long-term factor continu e-commerc segment oper margin expans amazon grow larger
infrastructur option faster-than-expect free cash flow growth vi -- vi advertis segment upward
bia aw revenu forecast like moder deceler path suggest on-going capit intens
valuat dcf-base price target base wacc termin growth increas vs
prior higher-than-expect capit intens either e-commerc platform aw risk price target
estim
receiv product pleas specifi credit suiss contact email call
sync interchang psr prelud lower estim
congest concern sound like get lost need better term network
perform take specif step address recent congest mexico includ leas loco
redeploy crew within central mexico right-siz custom equip modifi oper plan
monterrey yard shift switch activ sanchez yard monterrey also note
contempl longer term rethink brownsvil gateway build longer term capac histor
use bleed valv one hand fact compani leas power bit troubl know
ad asset clear congest make problem wors hand encourag hear
focus improv car cycl time hallmark psr work shipper mutual benefici
strategi reduc number car network sit yard given time inde shipper also
need psr
psr implement may hing upon also appear watch see mode respect
implement psr specif pertain interchang half cross-bord volum
interchang may forc chang oper strategi given run tight
schedul perhap dispel notion would good candid psr given rel high
exposur interchang class also indic noth structur within mexico
franchis labor agreement etc would prevent right-siz network simplif key compon psr
trim estim tp unchang estim declin forecast fall
respect tp remain risk includ unfavor trade polici
weaker expect volum growth maintain outperform
puls check deal rais target price
deal closur probabl high despit ny regul overhang octob doj preliminari approv
acquisit aet aetna reach agreement sell medicar part drug plan busi wellcar
health plan connecticut approv cvs-aet deal octob new york expect reach decis
oct point feel deal approv high probabl occur albeit time could slightli later
outlook earli close fact public hear yesterday maria vullo superintend new york
state depart financi servic rais concern relat potenti impact deal premium ny
note agenc block deal reason necessari believ ny regulatori oversight could play
similar ca regulatori process cnc-hnt deal merg parti agre certain concess
gain state approv overal junctur put probabl vs previous deal closur
tweak pt multipl stand-alon aet adjust pt multipl stand-alone aet
previous reflect recent manag chang announc compani uncertainti creat
regard outlook stand-alone aetna deal close impli one-year forward valuat
deal reject scenario includ per share break-up fee translat one-year forward price
target rang appli annual discount rate yield immedi trade price roughli
event deal go
adjust probabl weight price base updat probabl deal closur updat pt multipl
aet stand-alone current share price probabl weight pt aet vs prev risk
rate pt aet-cv deal get reject
receiv product pleas specifi credit suiss contact email call
go get tough estim reduc tp reduc
friday state street report third quarter earn per share fall short expect cs
consensu disappoint tie revenu fall short forecast invest servic fee particularli
weak expens came forecast enough off-set revenu shortfal gap larg fill
unanticip tax benefit per outgo ceo jay hooley year date result reflect solid perform across
busi investor quit see way share trade friday last quarter
reduc estim factor fee compress near term dilut relat charl river develop
acquisit quarter revenu shortfal lack offset oper leverag call question
achiev forecast growth estim reduc factor re-assess forward look less benefit
macro factor support revenu growth less oper leverag realiz reduc estim
per share estim come per share respect
target price reduc flow earn conserv assess secular pressur dcf
model reduc target price risk earn target price realiz tie macro factor level
short term interest rate market valu volum flows/mix chang competit landscap revenu
growth/pric pressur execut state street abil drive sustain oper leverag realiz
fujitsu come closer azur regist fujitsu confirm kill openstack-bas cloud
sale region outsid japan accord industri sourc fujitsu prefer cloud azur fujitsu confirm
plan train personnel short medium term azure-bas servic
amazon worker protest firm militari ai contract verg employe opposit tech
compani collabor us govern agenc keep grow base ethic concern use ai
militari purpos googl drop jedi contract bid process least partial due employe opposit
highlight defend contract follow similar protest expect stay cours bid
jedi
offic get tough phish enhanc protect releas report offic
phish result claim block phish email compani admit miss rate phish
email last year high rel major email provid led compani revamp enhanc anti-
phish capabl leverag annual secur spend post-revamp offic display lowest miss rate phish
email rel vendor set
launch expens manag app roll new garag project spend spend
on-the-go expens track solut autom data entri link user bank account card sever prior
garag project becom featur flagship product becom brand product believ product
focus small busi note expens manag smb competit market spend current
avail io us
receiv product pleas specifi credit suiss contact email call
bottom line report earn tuesday market close cc estimate expect
report mostli in-line guid modestli cs/street guidanc appear achiev
emb analog/embed bp season mostli in-line data model q/q
vr season see bp downsid insul limit suppli chain
china hub strategi shorter lead-tim better backlog scrutini compani immun macro forc
especi expos industrial/auto continu see y/i trough industri
still posit would need declin q/q y/i growth go neg lt
continu core hold manufactur diversifi end-market scale share gain
oper leverag cash return buy-back market cap would highlight
oper leverag continu expect opex under-grow opex y/i vs
y/i drive oper leverag opm first time see multi-year opm target approach
support lt fcfp
guidanc season guidanc appear achiev rel season expect
conserv manag err side caution amidst uncertain macro backdrop bar recess see
trough y/i growth roughli y/i
valuat compel durat sinc vs sarbanes-oxley stock current trade
ev/fcf discount largest discount sinc stock histor trough
ev/fcf impli stock current emb fcfp reduct reiter op pt
remain posit head result report octob highlight updat investor metric
 linkedin includ commerci cloud well slowdown capital-expenditure growth compani absorb prior
invest expect continu momentum commerci cloud anticip strong window corpor demand
off-set impact pc processor shortag low end
commerci cloud updat commerci portion linkedin linkedin revenu incorpor
commerci cloud result consensu commerci cloud revenu estim stand y/i believ
reflect recent report chang consensu azur growth stand y/i though convers lead us
believ buy-sid expect growth street estim y/i offic commerci growth
larg in-lin expect y/i separ channel check suggest favor demand
environ strong finish us feder year end septemb continu robust enterpris spend
strong corpor win recent pc shipment data support continu healthi window enterpris refresh
cycl street estim y/i expect window oem strength support strong
moder capital-expenditure growth tax payment compani guid moder capital-expenditure growth
convers suppli chain pick digest quarter model capital-expenditure capit
leas y/i vs y/i growth also highlight impact first tax
payment relat tax reform push estim y/i
valuat target price impli ev/ufcf multipl price-to-earnings multipl excl sbc
receiv product pleas specifi credit suiss contact email call
dupix asthma approv posit
expect fda approv asthma indic regn/sni dupix drug approv add-on
mainten therapi patient moderate-to-sever asthma year old eosinophil phenotyp oral
corticosteroid-depend asthma dupix inhibit two key protein
contribut inflamm may underli moderate-to-sever asthma dupix evalu across trial
rang month year durat drug effect patient high eosinophil count
exampl trial patient blood eosinophil cells/microlit greater dupix reduc sever
exacerb compar placebo improv lung function compar
placebo meanwhil patient eosinophil count less cells/microlit saw differ sever exacerb
rate drug vs placebo drug also demonstr benefit patient chronic corticosteroid dupix
administ everi week via subcutan inject
posit read-through etokimab dupix clinic activ moderate-to-sever eosinophil asthma derisk
etokimab approach etokimab act upstream dupix singl dose studi etokimab led rapid
improv lung function improv pbo day day improv also
line blood eosinophil reduct activ arm view etokimab outcom indic
potenti competit differenti profil space multi-dos phase pbo control asthma trial
expect initi atop dermat trial suggest attract monthli less frequent
administr may achiev
mcveigh weekli servic recap minut
substanti volatil market week rate-fuel gener risk sentiment continu
neg impact equiti theme-expens labor fuel -drove commerci servic stock week
competitor offer cautiou commentari oper environ wage input cost fuel drive
uk press stock
commerci servic preview top small-cap pick -we reiter select approach commerci servic
highlight pt top small-cap idea posit revis potenti multipl key peer
catalyst said reiter under-perform pt stock net unit volum declin like acceler
coupl high leverag rise rate neg impact stock
stock essenti discount recession-consist intra-day sell-off bring
stock essenti recess valuat underwhelm revenu margin headwind
remain balanc year confer call offer meaning confid manpow suggest
client convers mix albeit recessionari expect french temp european pmi
inflect result continu slow appropri weigh stock cut ep
prior cull addit ep continu cice headwind
result uk exposur support rel preference-w expect range-bound despit revenu
adj ep beat cse/st amid margin expans result
strong-storag solut revenu uk result tougher compar cost environment-even
synergies-impli less robust forward result strong top line result posit op pt
prefer valuation/estim upsid
headwind consist cintas-on wed offer underwhelm ep guid
street revenu guidanc rel in-line impli oper margin
street believ scope margin compress like exacerb size lack oper
leverag route-bas stock could underwhelm despit differ end market cost fuel
labor etc similar
receiv product pleas specifi credit suiss contact email call
surf hr lll ride consolid wave
publish preview week commerci preview found aerospac preview
fri pan defens note access defens preview get comfort also
attend unusu bullish nbaa show orlando publish takeaway note longer line disney
week come
monday octob report confer call et follow day
tuesday octob utx publish bmo call schedul respect
wednesday octob gd ba report bmo call respect
thursday octob rtn publish bmo call
hrs/lll announc merger equal harri corp technolog inc said sunday combin largest-
ever defens industri merger pentagon expand budget eye toward increas invest contractor
quicker weapon develop combin compani would product rang stretch militari radio
top-secret space hardwar air-traffic-control system amount overlap product limit
help new entiti cash bump pentagon spend spur presid trump come five
year cut wsj
cs bullish deal expect compani benefit combin wrote deal
extens note hail announc sixth defens prime market seem like deal well
stock close share pare gain slightli close week hr lll
forecast annual air cargo growth next year compani expect air cargo traffic
doubl freighter fleet grow asia like continu show fastest growth rate e-
commerc respons much expans market forecast doubl though combi aircraft
carri passeng freight becom popular structur characterist industri indic
dedic freighter like carri half world air cargo period
cs note line long-term histor averag though substanti higher growth
last decad expect boe benefit freight growth greater extent airbu given
command lead market
embraer report order deliveri embraer deliv commerci busi jet light
larg backlog decreas compani sign firm order aircraft
remov backlog account chang cancel compani press releas
cs figur light estim commerci busi jet deliveri light larg guidanc
impli uptick least commerci busi jet shipment appear demand
bizjet tend weight
trump dod budget probabl next year presid trump said defens depart budget
probabl billion potenti cut approxim though said depart
ask make cut defens news
cs degre uncertainti figur refer dod total nation defens
declin would appli overal nation defens budget presid trump instead refer budget
depart defens comment actual impli increas current level line project either
way signal era mid-singl digit defens budget growth may behind us wrote potenti budget
growth deceler extens defens downgrad domest fund fact start plateau intern
demand increasingli critic drive upsid defens stock seen increas intern
sale nearli across board though rtn still best known foreign content saudi tension offer
potenti risk howev
 -saudi defens tie track weather controversi diplomat storm surround suspect kill
journalist jamal khashoggi unlik derail multibillion-dollar relationship make saudi arabia top custom
 defens firm mr trump resist call curb arm sale saudi arabia turkish offici alleg
kingdom kill mr khashoggi saudi govern critic istanbul consul oct wsj
receiv product pleas specifi credit suiss contact email call
 nestl unilev spark hope higher price let get carri away
earn result week nestl unilev describ market gradual improv nestl
unilev price edg posit territori north america report surprisingli strong
volum growth result along continu macro concern help fuel anoth week sector rotat tech
defens sector admit read-through troubl food group must somewhat
posit unwind faang trade could continu help boost valuat still found sever reason
week maintain cautiou thesi food group
 unilev compet attract categori food beauti person tend respond better
reson product innov solv custom problem
unilev actual lower organ growth guidanc low end rang step forward price
 environ remain littl bit tough quit promot intens especi dress sever
sell-sid analyst lower target price
 said custom accept price increas help cover freight cost inflat commod
feedstock packag see also warn investor expect volum declin
elast demand possibl competitor take advantag situat short-term promot
let get carri away much price food compani actual go pass smucker
price went neg recent quarter price caus sharp volum declin
calendar expect price hershey despit recent announc
price increas price flat robust recoveri
could wrong food compani manag team longer head sand mani
new ceo recogn cut back far market product qualiti need
cede bigger big slice profit pie consum retail get back sustain organ growth conagra
success frozen food categori demonstr still possibl breath life antiqu brand
stagnant categori view compani need increas invest reset
margin lower particularli hershey smucker order get done
company-specif read-through posit neg
nestl point strong result purina divis probabl bad smucker also highlight
continu problem single-serv frozen entre take least develop new product
pipelin probabl good conagra
unilev commentari promot intens dress probabl reflect kraft heinz market share gain
mayonnais launch heinz mayo salad dress
homebuild homebuild stock coverag end week earn season group
start earnest next week expect temper demand rise afford concern weigh sentiment
broader group valuat offset near term earn beat come rate hike inflat pressur signal
move closer latter stage cycl lead persist multipl compress backdrop
downgrad lennar meritag neutral under-perform top pick remain dr horton given
geograph product exposur pult base abil drive averag margin return
build product build product group end week head earn expect
manag team strike posit tone demand like held quarter price effort continu come
much investor focu forward outlook though expect commentari
back hous call downgrad neutral week view compani
greater new home construct like see multipl compress focu name within
coverag lever repair remodel highlight fortun brand stanley
top articl week
toll brother turn prefab atlanta apart commun
nahb remodel market index yoy
sear file bankruptci
receiv product pleas specifi credit suiss contact email call
fall us natur ga rise finish push discount
brent driven anoth bearish us crude inventori build fourth consecut weekli build third
consecut weekli build came expect depress gasolin crack could lead possibl run
cut stronger us dollar meanwhil market seem shrug plethora news flow relat increas
tension saudi arabia disappear saudi journalist jamal khashoggi trump
administr seem get closer acknowledg saudi role view oner sanction saudi withhold
oil reaction unlik natur ga rose storag inject consensu
continu forecast colder weather
 ps under-perform broader market xop fell under-perform roughli flat
oili ps fell gas-lev ps rose
compani news publish earn preview smid-cap compani preview highlight page
attend israel investor tour last week prevail theme bullish outlook natur ga
region inflect point compani confirm longer pursu contract extens
expir oct idd el-shargi north dome project qatar product mbo
net sever ps pre-releas product miss expect due mainten
jackfish although volum recov full-scal oper mbo us oil product near
mid-point guidanc srci also report disappoint volum dcp constraint
former rais capital-expenditure budget latter provid product guidanc came
consensu beat expect product natur ga price announc sold overrid
royalti net acr washington counti pa impli attract cash flow vs pre-
deal ev/ebitdx proce use reduc debt cse net debt/ebitdx current
strip price put mid-contin asset western anadarko basin scoop/stack sale target
proce fund share repurchas and/or permian capital-expenditure
look week ahead sector earn season kick four compani report next week
expect eia report bcf natur ga storag inject thursday
lean week earn round
week posit read across assa abloy op kukhnin less favor though
outright neg read across atla copco yate quick commentari around
automot semi geograph end market
assa abloy posit read comfort sit consensu print
assa report america organ growth acceler versu year ago period
last three quarter assa report low doubl digit two-year growth stack
america assum trend hold see sale upsid segment forecast result addit
alreadi consensu forecast
electro-mechan el-mech sale grew ex-fx quarter assa within smart lock googl nest grew
faster digit lock tradit el-mech lock amazon saw low volum expect launch
compet amazon offer year end assa america profit margin declin yr/yr
declin organ balanc acquisit overal assa see better price/raw materi spread versu
european analyst note addit detail assab st assa abloy call solid
fundament thing look forward
receiv product pleas specifi credit suiss contact email call
gulf coast heavi light diff break even lls-maya spread critic gulf coast coke econom narrow
believ spread need get healthi return use heavi sour barrel lower clean
product yield physic side us refin util may padd run util
demand heavi sour crude remain high gc time venezuelan product
yoy continu go everi month result s/d maya much tighter normal
price side permian make maya price formula maya usgc hsfo ll brent
dtd permian crude discount narrow last month pemex abl push
significantli better price barrel make matter wors gc gasolin crack octan ad opex
/bbl gasolin cash margin neg gc crack diff work refin
could lead potenti run cut come season turnaround season neg energi
imo realli chang first continu believ current administr push phase implement
imo get support traction next week imo meet week mepc meet focu
success enforc ban hsfo ship without scrubber earn estim refin come
base friday event equiti market gener effici sell-off happen reason full
implement imo jan without delay binari event downsid risk went
presid unit state ask phase implant ensur fuel price spike go ahead market
adjust risk factor depend upon news flow next week meet bring risk
factor howev risk go away market convinc presid complet back low
probabl positon influenc outcom high probabl
crack neg major crack mix gc mid-west mid-con wc nyh
gasolin crack mix gc mid-con mid-west nyh wc
distil crack gc mid-west mid-con nyh wc
diff mix brent-wti widen wti-wc narrow mid-cush
narrow headwind permian refin
perform week refin perform market energi
cvrr outperform widen spread under-perform given higher leverag imo
seri unfortun event updat anoth blow boost
nsclc tmb high approv appear unlik opdivo yervoy provid anoth disappoint updat
on-going increasingli confus trial opdivo yervoy line non-smal cell
lung cancer nsclc follow updat expect share see pressur monday potenti
follow alreadi tough week hand continu see top pick base
progress make keytruda would expect upsid monday threat
nsclc like move
os hazard ratio similar high tmb group base addit analysi conduct european
regul overal surviv os benefit appear quit similar base hazard ratio compar
chemotherapi patient high level tumor mutat burden mut/mb low level lead
us wonder regul would approv regimen strictli patient high tmb per current file even
though absolut median os benefit greater tmb high group believ approv nsclc
may requir data part expect earli expect
think potenti approv nsclc may still month away
earn focu futur quarter expect deliv solid result
report earn thursday morn expect focu confer call mid-long term
outlook compani investor look visibl continu grow face
pressur lung cancer also growth indic adjuv melanoma renal cell carcinoma
near mid-term outlook appear strong driven keytruda gardasil ceo stay beyond dec
look visibl compani plan boost outlook time-frame
patent diabet blockbust januvia expir
maintain rate target price head earn maintain outperform rate target price
continu see top pick us pharma blue sky valuat grey sky valuat
maintain neutral rate target price blue sky valuat grey sky
valuat suggest risk/reward look interest follow recent sell-off stock
expect weak follow updat
receiv product pleas specifi credit suiss contact email call
investor survey suggest modest improv sentiment toward sector note review find
latest version quarterli investor sentiment survey investor respond survey long-onli
investor present key takeaway survey full result within bodi note long
investor becom optimist expect out-performance depend subsector
long/short investor see risk notabl pick percentag expect under-perform particularli
eu pharma mid cap biotech
sentiment us pharma remain quit posit us pharma perform well past month
respond gener expect continu ask group would perform rest said
would outperform vs felt way start said would perform in-lin market
said would under-perform expect balanc year us pharma group skew
posit cautious
eu pharma sentiment becom polaris broadli even spread expect
out-performance under-perform roch seen posit improv sentiment
investor choos best perform believ reflect recent comfort manag given
investor sustain sale earn despit expect us biosimilar launch novo seen
sharpest deterior sentiment survey time public strong data dual-act
debat gene therapi price note lack consensu price point gene therapi drug
file novarti prioriti review us price point potenti cur gene therapi
like becom point debat investor evenli distribut expect less
us healthcar reform potenti impact price respond thought pos rebat could
provid part next month thought full repeal safe harbour provis possibl
howev respond believ reform would impact drug price comparison
respond thought chang formulari remov protect statu part switch part part could
mid-high impact drug price part part reclassif consid like
ask number therapeut question look winner within migrain space investor see
amgen/novarti aimovig leader depress esketamin nash madrig
preliminari credit card spend acceler spend citi show
collect y/i increas visa emerg like winner visa primari partner non-costco
citi combin volum grew y/i note impact costco citi lap acceler
y/i saw acceler major big bank except addit
paymentech show notic acquir volum growth acceler
citi credit volum grew y/i credit volum grew
overal view result still posit visa though credit volum growth could acceler less
though believ posit gener bankcard network
debit growth bright spot continu acceler debit growth y/i follow
y/i debit card volum growth deceler y/i debit card volum
growth acceler y/i debit card growth acceler
y/i debit card volum grew vs larg visa bank
reiter outperform rate visa mastercard
receiv product pleas specifi credit suiss contact email call
take util ferc appear grab much attent last week sever import transmiss rule
roe methodolog independ adder posit es larg transmiss project gener
chairman mcintyr health issu possibl secretari perri support baseload coal nuclear might
hit new resist white hous howev last point note presid nomine ferc
bernard mcname known one secretari perri staunchest support coal nuclear need pass
senat confirm process
wednesday octob et thursday octob et note util
take renew global suppli glut remain place polysilicon cell manufactur continu
expans next year time guid least cost reduct technolog capac
improv nep report next week focu guidanc progress itc safe harbor impact
solar suppli glut cost competit storag
upcom group meet eei confer sf
psych hospit gener outsourc outperform question week
psych hospit gener outsourc outperform physician outsourc death under-perform week
end oct healthcar servic stock measur stock coverag average outperform
 broader hc sector hcx psych hospit gen outsourc
perform best physician outsourc death under-perform
 outperform md aet under-perform
perform best last week reuter report buy-out interest acadia healthcar compani inc buy-out
fever hit nashvil report in-lin strong cash flow in-lin
strong md aet under-perform
 week takeaway digit health fund report mercom capit group global commun
research firm publish report fund activ digit health sector first nine
month accord report global vc fund digit health compani higher y/i first
nine month bln rais deal vs bln deal first nine month total corpor
fund digit health compani came bln vs bln healthcar practice-focus compani
receiv fund healthcar consumer-centr compani receiv top fund
compani first nine month data analyt bln telemedicin bln mhealth
bln mobil wireless mln clinic decis support mln wearabl mln well
valuat major mco trade ep est ci least expens price-to-earnings hospit trade
litig financ also call litig fund practic third parti unrel lawsuit
provid capit plaintiff involv litig return portion financi recoveri lawsuit case
fund typic deriv one combin follow sourc plaintiff law firm
funds/bal sheet via anoth law firm split cost origin law firm litig financ
option estim grow preval
emerg risk commerci insur estim litig fund caus lawsuit frequenc
claim volum sever dollar amount paid per claim increas also estim asset class
continu grow given return remain outsiz one could make case institut investor would comfort
accept return consider lower rate current exhibit given asset class low correl
broader capit market perspect catastroph bond fund investor also non-correl asset class
current demand annual return decad ago estim commerci litig
financ current garner market share litig portion total legal spend figur believ doubl
receiv product pleas specifi credit suiss contact email call
pleas see detail earn preview
pleas announc credit suiss annual industri confer take place palm beach florida
novemb detail includ list particip compani inform registr pleas
click
thought print believ third quarter provid mix result clear energi cycl
turn particular coupl broad-bas strength off-shore petrochem pipelin view
proxi group announc compani grow backlog end reflect
canada also driven petrochem mine award golden pass expect go fid year
end also see award momentum continu earli fid expect woodfibr calcasieu pass
well mozambiqu eni anadarko mozambiqu mdr track north petrochem project north
america alon anoth mine project look three primari winner big
energi relat coverag univers includ mdr believ bid joint ventur
preval given size contract order mitig risk believ strength time cycl
contractor surpris well sequenc project properli align resourc becom increasingli
import think craft labor shortag also becom topic like get wors sit today
contractor still bear risk result fix price contract cycl capac
constraint preval market shift cost plu happen although remain skeptic
would lead massiv multipl expans group specialti contractor believ focu
visibl pipelin abil harvest good margin cash flow well time
commun ramp bottom line expect bullish tone term posit book momentum year end
still battlefield book outlook upbeat still risk nois earn tie cost
overrun legaci problem project time earn contribut select project alreadi pre-announc
neg relat overrun power downstream project mdr stock weak
file shelf drive concern overrun cameron balanc sheet need increment
strengthen handl massiv award flow investor concern earn could shift
certain pipelin job tie delay hurrican disrupt flow import
bottom line third quarter result could present fair degre nois howev believ commentari earn
trajectori import given pend backlog growth
issu compani jec investor focus portfolio optim capit alloc
guidanc alreadi clariti think qualiti backlog confus call
post pre-announc earn guid given backlog growth time magnitud repo
mdr investor want clariti shelf updat problem project risk associ deal
particular cameron timelin de-lever investor want closur ichthi confid
earn break-out scenario plausibl well potenti split govern energi
margin book particular pipelin focu earn risk mvp hit cash flow
find hot spot hous heat map
traffic contract growth deceler aggreg result nine market track show momentum continu
slow sinc reach year-to-d peak may trail basi net contract rose year year vs
increas last month traffic year year compar declin august declin led
southern california traffic yoy san diego traffic yoy addit normal season
consist channel check show area rel afford see greater demand vs higher-cost west
west southeast lead permit gain build permit serv lead indic start provid insight
upcom activ level consist trend seen past year gain month led state west
southeast region countri colorado arizona florida yoy ttm basi
although condit california remain healthi permit increas last year note held
low rang saw much state saw growth vs last month includ
experienc increas greater vs august
valuat target price base averag forward adj book valu outperform rate name
receiv product pleas specifi credit suiss contact email call
rememb rememb novemb
past month common topic convers investor defens stock behav
past elect cycl differ elect outcom may interpret market current cycl
note seek answer question review histor elect outcom associ stock price
impact pair data perspect elect similar upcom one len
develop expect defens share might behav differ scenario ultim think defens could
trade democrat take hous take hous senat republican retain
major chamber see potenti upsid assum poll data chang significantli prior
elect negat upsid surpris refer figur summari elect outcom sinc
elect saw defens under-perform may first glanc appear
reason guidepost sensit potenti impact defens stock elect midterm
elect republican presid contest republican control hous senat
economi upsw defens spend upcycl poll appear broadli favor toward
democrat limit market surpris neg outcom
howev elect differ one crucial respect specif natur defens upcycl
current defens upcycl sharpli differ upcycl driven primarili hot-war
command chief larg held exclus purview accordingli defens spend much less sensit
congression oversight congress larg cede respons war-and costs-to presid
definit case current upcycl current upcycl driven instead need recapit dod
recov neg effect sequest see defens primer well counter resurg russia
rise china spend exclus congression control increas dod budget hing
accommod repres senat appropri money
though democrat will spend heavili defens past see defens primer
sometim take less favor view toward defens seek fund compet prioriti support point
current cycl note rep adam smith d-wa rank member hasc previous state defens
spend high think near-term downsid contractor limit due strong growth
budget expect defens budget grow long-term larg part due rivalri china think
democrat take-over could net neg medium-term growth stori defens perhap importantli
sentiment market
receiv product pleas specifi credit suiss contact email call
ut issu rfp telehealth vendor contract last week univers texa scienc center
houston uthealth releas request propos rfp select telehealth contractor uthealth expect
new telehealth system interfac uthealth current ehr system current vendor allscript revenu cycl
manag system current vendor ge centric busi hub-and-spok provider-driven telehealth market
still earli stage rfp provid look need focu area major health system perspect
way background ut health made six differ school harri counti psychiatr center
contract durat timelin addit busi opportun initi term agreement expect
five year begin februari univers may elect renew agreement two addit one year
term separ uthealth part univers texa ut compris fourteen
institut accord rfp ut system institut routin evalu whether contract result
procur conduct one institut might suitabl use anoth rfp could give rise
addit busi opportun beyond uthealth contract vendor
rfp outlin forc drive uthealth desir provid telehealth servic uthealth/ut physician serv
ever-grow geograph region throughout state even branch outsid nation border time in-
person visit simpli realist option accord rfp addit rfp highlight rapidli increas
familiar comfort electron commun factor highlight includ custom driven
approach help provid meet patient reduc drive time physician embrac
evolv technolog make part cultur
minimum qualif criteria impli scale matter accord rfp telehealth vendor must work
five larg institut physician current use technolog institut must
facilit patient/physician interact annual separ telehealth propos due
number evalu base follow factor compani background/history/financi strength/r
technic capabl servic implement methodolog mainten
uthealth scope work
favor telemedicin regul like continu drive provid push telehealth adopt texa
telemedicin law sign last year creat new opportun healthcar provid care patient outsid
tradit physician offic hospit visit instanc law remov texa medic board tmb author
establish blanket requir initi in-person visit addit law remov requir clinic
place servic long standard care uncompromis previous tmb impos certain requir base
locat patient new rule remov locat distinct place emphasi instead establish
patient-physician relationship enabl healthcar provid establish doctor-pati relationship telehealth
separ juli year announc sever propos boost remot patient monitor telehealth
program improv reimburs final rule expect novemb
receiv product pleas specifi credit suiss contact email call
headlin price previou day close unless otherwis note
compani mention price oct
america corp outperform tp
receiv product pleas specifi credit suiss contact email call
